Semaglutide vs Tirzepatide: What's the Difference?

Semaglutide and tirzepatide are two different medications, not two names for the same drug. Semaglutide activates the GLP-1 receptor, while tirzepatide activates both the GIP and GLP-1 receptors. In head-to-head research, tirzepatide has produced greater average weight loss, but the better choice for any individual depends on health history, tolerability, and insurance coverage.

What Are Semaglutide and Tirzepatide?

Semaglutide is a GLP-1 receptor agonist sold under several brand names. Ozempic and Rybelsus are approved for type 2 diabetes, while Wegovy is approved for chronic weight management.

Tirzepatide is a dual GIP and GLP-1 receptor agonist. It is marketed as Mounjaro for type 2 diabetes and as Zepbound for weight loss.

Both drugs mimic gut hormones that influence appetite and digestion. They slow stomach emptying, increase feelings of fullness, and reduce how much a person eats. That shared mechanism is why both are often grouped together as GLP-1 medications, even though tirzepatide also acts on the GIP receptor.

Semaglutide vs Tirzepatide: Side-by-Side Comparison

Feature	Semaglutide	Tirzepatide
Drug class	GLP-1 receptor agonist	Dual GIP and GLP-1 receptor agonist
Brand names	Ozempic, Wegovy, Rybelsus	Mounjaro, Zepbound
Approved for weight loss	Yes (Wegovy)	Yes (Zepbound)
Typical weekly maintenance dose	1.7 mg to 2.4 mg	5 mg to 15 mg
Average weight loss in trials	About 15% of body weight	About 21% of body weight
Common side effects	Nausea, vomiting, diarrhea, constipation	Nausea, vomiting, diarrhea, constipation
How it is taken	Weekly injection or daily oral tablet	Weekly injection

Semaglutide and tirzepatide are not interchangeable at the same dose, and a milligram of one drug does not equal a milligram of the other.

Which Produces More Weight Loss?

In the SURMOUNT-5 head-to-head trial, adults with obesity taking tirzepatide lost roughly 20% of their body weight over 72 weeks, compared with about 14% for those taking semaglutide. Trials of each drug on its own pointed in the same direction, with about 21% average weight loss for tirzepatide in SURMOUNT-1 and about 15% for semaglutide in STEP 1.

Clinical data on semaglutide vs tirzepatide weight loss reports group averages from large studies. Individual results vary widely based on dose, treatment duration, diet, activity level, and how consistently someone stays on the medication.

When people ask tirzepatide vs semaglutide which is better for weight loss, the trial data give tirzepatide the edge. That statistical advantage does not mean tirzepatide is automatically the right option for every patient.

Neither drug is a cure for obesity or diabetes. Weight regain is common after stopping either medication, which is why both are generally intended for long-term use alongside diet and exercise.

Dosing, Cost, and Brand Names

Ozempic vs Wegovy: Same Drug, Different Labels

Ozempic and Wegovy contain the same active ingredient, semaglutide, but they are approved for different uses and sold at different maximum doses. Someone asking is semaglutide the same as ozempic should know that Ozempic is one brand of semaglutide rather than a separate medication.

Compounded semaglutide is not the same as Ozempic. Compounded products are not FDA-approved, and their strength, purity, and dosing instructions can differ from pharmacy to pharmacy.

Dosing Schedules and Price

Guidance on tirzepatide vs semaglutide dosage for weight loss differs because each product follows its own titration schedule. Wegovy is usually stepped up to a maintenance dose of 1.7 mg or 2.4 mg once weekly, while Zepbound is typically increased to somewhere between 5 mg and 15 mg once weekly.

List prices for both drugs run well over $900 per month without insurance, although manufacturer savings programs and insurance coverage can lower that number substantially. Coverage varies by plan, and many insurers require prior authorization or a documented type 2 diabetes diagnosis.

Side Effects, Hair Loss, and Safety

Semaglutide and tirzepatide share a similar side effect profile. Nausea, vomiting, diarrhea, and constipation are the most common complaints, and they often ease as the body adjusts to a new dose.

Discussion of tirzepatide vs semaglutide hair loss is widespread online. Hair shedding is more often linked to rapid weight loss, low protein intake, and nutritional gaps than to either drug directly, and it usually improves once weight stabilizes.

Serious but uncommon risks include pancreatitis, gallbladder disease, and kidney problems caused by severe dehydration. Both drugs carry a boxed warning about thyroid C-cell tumors and are not recommended for people with a personal or family history of medullary thyroid cancer or MEN2 syndrome.

Anyone considering these medications should talk with a licensed healthcare professional before starting, switching, or stopping treatment.

How to Choose Between Them

Most clinicians weigh a handful of practical factors rather than picking a winner on paper:

• Insurance coverage: the drug your plan covers is often the deciding factor.
• Tolerability: some people handle one drug's side effects better than the other's.
• Weight loss goal: a larger target may favor tirzepatide based on trial averages.
• Other health conditions: kidney disease, pancreatitis history, and thyroid history all matter.
• Cost and access: brand-name pricing, savings cards, and pharmacy supply vary by region.

Some people also ask about switching from one drug to the other mid-treatment. A clinician may restart the titration process from a lower dose to reduce gastrointestinal side effects.

Searches for retatrutide vs tirzepatide which is better are already common, even though retatrutide is still investigational and not approved for human use. Newer options may change this comparison in the coming years, but for now the choice comes down to semaglutide and tirzepatide.

COMMON QUESTIONS

Frequently Asked Questions

Is semaglutide the same as Ozempic?

Ozempic is a brand name for semaglutide, so the active ingredient is the same. The difference is the label: Ozempic is approved for type 2 diabetes, while Wegovy, also semaglutide, is approved for weight loss at a higher maximum dose. Compounded semaglutide is a separate, non-FDA-approved product.

Which is better, semaglutide or tirzepatide?

In head-to-head trial data, tirzepatide produced greater average weight loss than semaglutide. However, better is not the same as right for everyone, since insurance coverage, side effect tolerance, and personal health history often determine which medication a clinician recommends.

Can you switch from semaglutide to tirzepatide?

Switching is possible with a clinician's guidance, but the doses are not equivalent, so treatment usually restarts at a low dose and titrates upward. People who switch often report a return of gastrointestinal side effects during the ramp-up period. Never change medications without medical supervision.